Study Finds Women With PMOS Face Significantly Higher Cardiovascular Disease Risk

Women with PMOS — recently renamed from PCOS — face significantly elevated cardiovascular disease risk, new research finds.

Women diagnosed with polyendocrine metabolic ovarian syndrome (PMOS) have a significantly higher risk of developing cardiovascular disease, according to new research. The study adds to growing evidence that the condition — which affects an estimated 1 in 10 women of reproductive age — carries serious long-term health consequences beyond its more commonly discussed symptoms. The condition was renamed from polycystic ovary syndrome (PCOS) to PMOS in May, a change intended to better reflect its hormonal and metabolic nature rather than focusing solely on ovarian cysts, which not all patients have. The new name emphasizes how the syndrome disrupts multiple endocrine pathways, affecting metabolism, hormones, and reproductive function. Researchers found that women with PMOS face elevated risks not only for cardiovascular disease but also for associated conditions including type 2 diabetes and mental health disorders. The cardiovascular risk finding is described as 'significant,' though the precise magnitude of increased risk and the study's methodology are not fully detailed in available reporting.

Why it matters

Cardiovascular disease is the leading cause of death in women globally, and identifying PMOS as a significant risk factor could prompt earlier screening and preventive care for the millions of women affected. The recent renaming of the condition may also shift clinical focus toward its systemic metabolic effects, potentially improving diagnosis and treatment.

What's next

It is not yet clear whether the findings will prompt updated clinical guidelines for cardiovascular screening in women with PMOS.

Key facts

• The condition was renamed from PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome) in May
• Women with PMOS face a 'significantly' higher risk of cardiovascular disease, according to the new study
• PMOS is also linked to elevated risks of type 2 diabetes and mental health conditions
• The renaming was intended to reflect the condition's hormonal and metabolic nature more accurately
• PMOS affects an estimated 1 in 10 women of reproductive age

Bias & framing notes

Both sources report the same core finding but provide limited methodological detail about the underlying study — sample size, study design, and the precise degree of cardiovascular risk increase are absent from available reporting. The Independent's headline uses vague language ('could increase') while the ABC headline cites the study's own characterization of 'significantly' higher risk. Neither source offers substantial critical or dissenting perspective on the research.

NewsClear — neutral news & congressional tracking · Bill of the Week